[go: up one dir, main page]

WO2008008628A3 - Structure cristallisée d'itpk1 et utilisations - Google Patents

Structure cristallisée d'itpk1 et utilisations Download PDF

Info

Publication number
WO2008008628A3
WO2008008628A3 PCT/US2007/072280 US2007072280W WO2008008628A3 WO 2008008628 A3 WO2008008628 A3 WO 2008008628A3 US 2007072280 W US2007072280 W US 2007072280W WO 2008008628 A3 WO2008008628 A3 WO 2008008628A3
Authority
WO
WIPO (PCT)
Prior art keywords
itpk1
crystal structure
coordinates
studying
crystallized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/072280
Other languages
English (en)
Other versions
WO2008008628A2 (fr
Inventor
Philip Chamberlain
Glen Spraggon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IRM LLC
Original Assignee
IRM LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IRM LLC filed Critical IRM LLC
Publication of WO2008008628A2 publication Critical patent/WO2008008628A2/fr
Publication of WO2008008628A3 publication Critical patent/WO2008008628A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Molécule d'ITPK1 cristallisée. On obtient les coordonnées 3D de cette structure par diffraction de rayons X et lesdites coordonnées peuvent être utilisées pour l'étude de la structure d'ITPK1, ainsi que pour la conception, la recherche et le développement de composés qui modulent l'activité d'ITPK1.
PCT/US2007/072280 2006-07-14 2007-06-27 Structure cristallisée d'itpk1 et utilisations Ceased WO2008008628A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83088306P 2006-07-14 2006-07-14
US60/830,883 2006-07-14

Publications (2)

Publication Number Publication Date
WO2008008628A2 WO2008008628A2 (fr) 2008-01-17
WO2008008628A3 true WO2008008628A3 (fr) 2008-05-02

Family

ID=38924010

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/072280 Ceased WO2008008628A2 (fr) 2006-07-14 2007-06-27 Structure cristallisée d'itpk1 et utilisations

Country Status (1)

Country Link
WO (1) WO2008008628A2 (fr)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHAMBERLAIN PHILIP P ET AL: "Integration of inositol phosphate signaling pathways via human ITPK1", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 38, September 2007 (2007-09-01), pages 28117 - 28125, XP002468067, ISSN: 0021-9258 *
GILLILAND G L ET AL: "The Biological Macromolecule Crystallization Database: crystallization procedures and strategies", ACTA CRYSTALLOGRAPHICA SECTION D: BIOLOGICAL CRYSTALLOGRAPHY, MUNKSGAARD PUBLISHERS LTD. COPENHAGEN, DK, 2002, pages 916 - 920, XP003012812, ISSN: 0907-4449 *
JHOTI H: "High-throughput structural proteomics using x-rays", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 19, no. 10, 1 October 2001 (2001-10-01), pages S67 - S71, XP004310381, ISSN: 0167-7799 *
MILLER GREGORY J ET AL: "Specificity determinants in inositol polyphosphate synthesis: Crystal structure of inositol 1,3,4-trisphosphate 5/6-kinase", MOLECULAR CELL, vol. 18, no. 2, April 2005 (2005-04-01), pages 201 - 212, XP002468066, ISSN: 1097-2765 *
WILSON M P ET AL: "Isolation of inositol 1,3,4-triphosphate 5/6-kinase, cDNA cloning and expression of the recombinant enzyme", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 271, no. 20, 17 May 1996 (1996-05-17), pages 11904 - 11910, XP002974240, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2008008628A2 (fr) 2008-01-17

Similar Documents

Publication Publication Date Title
WO2008109871A8 (fr) Structure cristalline de proprotéine convertase 9 (pcsk9) et utilisations de celle-ci
PL1795576T3 (pl) Sposób wytwarzania węglowodorów
IL231919A0 (en) Antibodies against cd38 for treatment of multiple myeloma
EP1853313A4 (fr) Anticorps humanises l243
IL185110A0 (en) Processes for the production of organometallic compounds
PL1896426T3 (pl) Sposób syntezy związków organicznych
IL184343A0 (en) Gitr antibodies for the diagnosis of nsclc
SI1947933T1 (sl) Sistem za nadzirano nanaĺ anje herbicidov
HUE043068T2 (hu) Eljárás elágazó láncú szénhidrogén komponens elõállítására
DE602006003238D1 (de) Fehlerverschleierung für Videosignale
WO2008008628A3 (fr) Structure cristallisée d'itpk1 et utilisations
NO20093576L (no) Aluminapartikler og fremgangsmater for a frembringe de samme
WO2007134262A3 (fr) Structure cristalline de la prostasine et ses applications
WO2008143894A3 (fr) Rala phosphorylé
WO2006074464A3 (fr) Modulation de l'activite du recepteur de type toll
GB0505861D0 (en) Methods for the synthesis of heteroaromatic compounds
HK40116860A (en) Antibodies against cd38 for treatment of multiple myeloma
HK1121736A (en) Modulators of the h3 receptor useful for the treatment of disorders related thereto
FR2911703B1 (fr) Procede de modelisation du rayonnement acoustique d'une structure complexe.
AU2005901787A0 (en) Method of screening for compounds that modulate cell proliferation
HK1109895A (en) 1,2-dihydro-spiro(3h-indole-3-4 -piperidine) compounds as modulators of the mas receptor novel
AU2005903531A0 (en) Method for assessing the costs of policy options
WO2009115664A3 (fr) Structure cristalline du domaine cc2-lz de nemo
FI20055664A0 (fi) Prosessi haarautuneen hiilivetykomponentin valmistamiseksi
AU2007905420A0 (en) Method for screening compounds that regulate phosphatase activity

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07812389

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07812389

Country of ref document: EP

Kind code of ref document: A2